Lyka Labs Ltd

NSE: LYKALABS · BSE: 500259 · Pharmaceuticals & Biotechnology · 24 announcements

Share price: ₹74.85
Market cap: ₹267.1 Cr
Revenue (annual): ₹128.4 Cr
Net profit (annual): ₹-10.03 Cr
P/E (TTM): -30.0×Sector 47.4×
Promoter holding: 58.45%+0.29% QoQ
FII holding: 0.17%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 4 Price Movement Clarification 3 Other Announcement 3 Annual General Meeting 3 Promoter Buying 2 Board Meeting Date 2 Results Update 1 Results Correction 1 Legal & Regulatory 1 Fund Raise 1 Credit Rating 1 Annual Report 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

30 Apr 2026 17:08 IST NSE

Credit Rating

Lyka Labs Credit Rating

Lyka Labs Limited announced that India Ratings & Research Pvt. Ltd. has affirmed its credit rating for ₹33.28 Crore (INR 332.8 million) in bank facilities. The long-term rating is IND BBB+/Stable and the short-term rating is IND A2.

Value: ₹33.28 Cr

Read the filing ↗